Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Visumax Femtolasik Versus Moria M2 Microkeratome in Mild to Moderate Myopia: Efficacy, Safety, Predictability, Aberrometric Changes and Flap Thickness Predictability

NCT03193411 is registered in ClinicalTrials.gov with Dar Al Shifa Hospital as lead sponsor.

NCT NCT03193411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03193411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Visumax Femtolasik Versus Moria M2 Microkeratome in Mild to Moderate Myopia: Efficacy, Safety, Predictability, Aberrometric Changes and Flap Thickness Predictability
Lead sponsor
Dar Al Shifa Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2014
Completion date
June 30, 2014
Enrollment
30 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lasik in myopia